NCT04542954

Brief Summary

Methods: Out of 2000 kidney transplant recipients in our center in Kuwait, collecting data was started for all COVID-19-positive kidney transplant recipients till August 2020. Clinical features, management details and both patient and graft outcomes were reported.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2020

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 7, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 9, 2020

Completed
Last Updated

September 9, 2020

Status Verified

September 1, 2020

Enrollment Period

6 months

First QC Date

September 7, 2020

Last Update Submit

September 8, 2020

Conditions

Covid19Kidney Transplant InfectionRisk Factor, CardiovascularImmunosuppressionOutcome, FatalGraft Failure

Outcome Measures

Primary Outcomes (2)

  • patient outcome

    living patients (1), dead patients(2) during the study period

    30 days

  • Kidney graft outcome

    functioning graft(1), failed graft(2) and impaired graft(3) at the end of the study

    30 days

Secondary Outcomes (1)

  • risk factors for getting COVID19 infection

    30 days

Interventions

Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience from the Middle EastOTHER

Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience from the Middle East

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All Adult renal transplant patients infected with COVID-19 during the period of 6 months from 3.2020 till the end of 8.2020

You may qualify if:

  • All renal transplant patients infected with COVID-19 during the period of 6 months from 3.2020 till the end of 8.2020

You may not qualify if:

  • Pediatric patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OTC, MOH , Kuwait

Kuwait City, Kuwait, Kuwait

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
30 Days
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 7, 2020

First Posted

September 9, 2020

Study Start

March 1, 2020

Primary Completion

August 31, 2020

Study Completion

August 31, 2020

Last Updated

September 9, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations

KU(1)